Cannabis made another leap forward in 1964 when Israeli scientist Dr. Raphael Mechoulam identified the structure of delta-9-tetrahydrocannabinol, or THC. This discovery earned him godfather status of modern cannabis. This particular discovery allowed science to understand THC’s nature as a psychoactive compound in cannabis as well as CBD’s non-intoxicating but vastly therapeutic benefits.
People all over the country love to buy CBD Oil Lotions because they perform double duty. Not only do they help to smooth and soften the skin where its placed, they also allow you to administer the cannabidiol, or CBD, directly to the area where you want it. Many people swear by their CBD Oil Lotion. While the FDA prevents us from making any health claims, we can definitely tell you that many people buy them regularly for their arthritis or aging aching joints.
A 2014 study stated that, “The endocannabinoid system has been elucidated over the last several years, demonstrating a significant interface with pain homeostasis. Exogenous (plant-based) cannabinoids have been demonstrated to be effective in a range of experimental neuropathic pain models, and there is mounting evidence for therapeutic use in human neuropathic pain conditions.”
Many food and beverage companies are already taking advantage of the growing CBD trend and adding CBD to food and beverage products, though the practice is not approved by the FDA. They are mostly using purified CBD (CBD isolate) instead of CBD oil, because purified CBD has no significant taste and comes from poorer quality hemp, which is cheaper to produce. Whether it’s completely safe is totally unknown.
Cannabis consumers have long prized potency (a high THC content) as one of the main factors that makes a particular strain more desirable. Though traditional demand for THC has caused an oversaturation of high-potency products, many consumers are starting to prefer less intense products that are lower in THC and higher in the non-intoxicating compound called cannabidiol (CBD).
Endocannabinoids are cannabinoids made by the body. Phytocannabinoids are cannabinoids made by plants. Hemp Oil + is a synergistic blend of phytocannabinoids (and other active ingredients) from hemp stalk oil, clove, black pepper, hops, and rosemary. Blended in a base of nutritionally-rich hemp seed oil, these ingredients nourish the body’s endocannabinoid system – or ECS.* The ECS – its importance has only recently been realized – is being referred to as the most important body system you’ve never heard of.
Ringo’s Gift: This cultivar is named after the cannabidiol pioneer, Lawrence Ringo. Ringo’s Gift is a cross between two other CBD-rich strains, AC/DC and Harle-tsu. Its CBD to THC ratio varies from 1:1 to 22:1, but it consistently favors CBD. Ringo’s Gift smells of earthy pine and promises full-bodied relaxation in tandem with calming cerebral effects which, together, silence pain and anxiety.
Cannabidiol, a non-euphoriant phytocannabinoid common in certain strains, shares neuroprotective effects with THC, inhibits glutamate neurotoxicity, and displays antioxidant activity greater than ascorbic acid (vitamin C) or tocopherol (vitamin E) (Hampson et al 1998). While THC has no activity at vanilloid receptors, CBD, like AEA, is a TRPV1 agonist that inhibits fatty acid amidohydrolase (FAAH), AEA’s hydrolytic enzyme, and also weakly inhibits AEA reuptake (Bisogno et al 2001). These activities reinforce the conception of CBD as an endocannabinoid modulator, the first clinically available (Russo and Guy 2006). CBD additionally affects THC function by inhibiting first pass hepatic metabolism to the possibly more psychoactive 11-hydroxy-THC, prolonging its half-life, and reducing associated intoxication, panic, anxiety and tachycardia (Russo and Guy 2006). Additionally, CBD is able to inhibit tumor necrosis factor-alpha (TNF-α) in its own right in a rodent model of rheumatoid arthritis (Malfait et al 2000). At a time when great concern is accruing in relation to NSAIDs in relation to COX-1 inhibition (gastrointestinal ulcers and bleeding) and COX-2 inhibition (myocardial infarction and cerebrovascular accidents), CBD, like THC, inhibits neither enzyme at pharmacologically relevant doses (Stott et al 2005a). A new explanation of inflammatory and analgesic effects of CBD has recently come to light with the discovery that it is able to promote signaling of the adenosine receptor A2A by inhibiting the adenosine transporter (Carrier et al 2006).
The wide range of benefits associated with cannabis have garnered interest for use in cancer therapy. Research suggests that cannabinoids, including CBD, may have anti-tumor effects. While this is not enough to define cannabis as a treatment for cancer, it does make it attractive as a complement to other therapies, for both reducing symptoms and possibly enhancing the effects of anticancer drugs.
Ingredients: Aloe Barbadensis (Aloe Vera) Leaf Juice*, Purified Water, Carthamus Tinctorius (Safflower) Oleosomes, Butyrospermum Parkii (Shae) Butter*, Cocos Nucifera (Coconut) Oil*, Vegetable Glycerin**, Cetearyl Olivate, Sorbitan Olivate**, Mangifera Indica (Mango) Seed Butter*, Lactobacillus Ferment (from Cabbage)**, Lactobacillus, Cocos Nucifera (Coconut) Fruit Extract**, CW Hemp Oil CO2 Extract, Mentha Piperita (Peppermint) Leaf Extract, Arnica Montana Flower Extract, Curcuma Longa (Turmeric) Root Extract, Salix Alba (Willow) Bark Extract, Cimicifuga Racemosa (Black Cohash) Root Extract, Prunus Armeniaca (Apricot) Kernel Oil*, Simmondsia Chinensis (Jojoba) Seed Oil*, Glyceryl Stearate (Palm Oil Derived), Xanthan Gum, Panthenol (Vitamin B5), Tocopheryl Acetate (Vitamin E), Cyamopsis Tetragonolobus (Guar) Gum*, Sodium Benzoate, and Potassium Sorbate.
Cannabidiol (CBD) is a naturally-occurring constituent of industrial hemp (cannabis sativa) plants. It is the most abundant non-psychoactive cannabinoid found in cannabis and is being scientifically investigated for numerous reasons. Most people have heard of a cannabinoid called THC, which is the ingredient in cannabis that gets users high. Unlike THC, CBD (cannabidiol) is a non-psychoactive cannabinoid and does not cause a high.
"Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases. The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease and HIV dementia.
3) If you live in a state where there’s a lot of choice, I encourage you to do some research to find dispensaries that genuinely seem to cater to medical consumers. Some dispensaries even in states where cannabis is only medically legal mostly are aimed at recreational users. At medical places, employees will be knowledgeable about dosages, the menu will be very clear about dosages and usages, there will be a wide range of CBD products, and some will even offer additional medical or educational services such as workshops or visits with cannabis-friendly herbalists.

CBD tinctures are some of the best all-around CBD products! It’s hard to beat the convenience of having a few drops from a tincture as part of your morning routine or taking the travel size with you on the go to use at your discretion. Looking for something more convenient and more effective? Check out our Full Line of CBD Capsules, Vape Pens, and CBD Balms and Lotions
The dosages mentioned do not take into account the strength of the tincture. I have Elixinol 300, I took 1/2 dropper (0.5ml, which offers 5mg of CBD) as indicated on the bottle and felt severely nauseous for 3 hours thereafter. There is no way I cold take this dose twice per day, as recommended on the bottle. The high dosages on this site must surely be for much weaker concentrations?
CBD is not addictive. ‘An addiction to marijuana can develop as a severe form of "marijuana use disorder" which affects an estimated 30 per cent of marijuana users,' says Dr Brewer. 'This develops from a dependence on the psychoactive ingredient, THC, which is found in marijuana strains of cannabis, and which can cause a high and withdrawal symptoms.’

Results of a Phase III study (N = 177) comparing Sativex, THC-predominant extract and placebo in intractable pain due to cancer unresponsive to opiates (Johnson and Potts 2005) demonstrated that Sativex produced highly statistically significant improvements in analgesia (Table 1), while the THC-predominant extract failed to produce statistical demarcation from placebo, suggesting the presence of CBD in the Sativex preparation was crucial to attain significant pain relief.
For anybody with chronic pain, some forms of body contact can cause intense pain, which may lead some people to avoid being touched. If left unchecked, this can turn into a serious problem that affects your personal and social life. What makes CBD perfect for pain is that it works in the central nervous system to reduce intense feelings of pain and encourage more positive feelings through the release of certain chemical compounds and the workings of CB2 receptors. Once you start using CBD, you will be more receptive to touch, and this will be a positive thing.
×